Thomas Eigentler

Thomas Eigentler

Universität Tubingen - Tübingen / Germany
Medical and Health Sciences / Dermatology and Venereology
AD Scientific Index ID: 1787556
Eberhard Karls University of Tübingen
person_outline Thomas Eigentler's MOST POPULAR ARTICLES
1-) Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trialA Ribas, I Puzanov, R Dummer, D Schadendorf, O Hamid, C Robert, ...The lancet oncology 16 (8), 908-918, 201515602015
2-) Epidemiology of skin cancerJ Reichrath, U Leiter, T Eigentler, C GarbeSunlight, vitamin D and skin cancer, 120-140, 20147172014
3-) Systematic review of medical treatment in melanoma: current status and future prospectsC Garbe, TK Eigentler, U Keilholz, A Hauschild, JM KirkwoodThe oncologist 16 (1), 5-24, 20117122011
4-) Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapyL Hofmann, A Forschner, C Loquai, SM Goldinger, L Zimmer, S Ugurel, ...European journal of cancer 60, 190-209, 20166952016
5-) Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the …R Gutzmer, D Stroyakovskiy, H Gogas, C Robert, K Lewis, S Protsenko, ...The Lancet 395 (10240), 1835-1844, 20206452020